- Home
- DDOG vs KVUE Comparison
DDOG vs KVUE Comparison
Compare DDOG & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DDOG
- KVUE
- Stock Information
- Founded
- DDOG 2010
- KVUE 2022
- Country
- DDOG United States
- KVUE United States
- Employees
- DDOG N/A
- KVUE N/A
- Industry
- DDOG Computer Software: Prepackaged Software
- KVUE Specialty Chemicals
- Sector
- DDOG Technology
- KVUE Consumer Discretionary
- Exchange
- DDOG Nasdaq
- KVUE Nasdaq
- Market Cap
- DDOG 35.1B
- KVUE 40.9B
- IPO Year
- DDOG 2019
- KVUE 2023
- Fundamental
- Price
- DDOG $127.50
- KVUE $21.40
- Analyst Decision
- DDOG Buy
- KVUE Buy
- Analyst Count
- DDOG 33
- KVUE 12
- Target Price
- DDOG $143.33
- KVUE $25.33
- AVG Volume (30 Days)
- DDOG 4.5M
- KVUE 19.0M
- Earning Date
- DDOG 08-07-2025
- KVUE 08-05-2025
- Dividend Yield
- DDOG N/A
- KVUE 3.83%
- EPS Growth
- DDOG 45.28
- KVUE N/A
- EPS
- DDOG 0.47
- KVUE 0.55
- Revenue
- DDOG $2,834,575,000.00
- KVUE $15,302,000,000.00
- Revenue This Year
- DDOG $22.94
- KVUE $3.02
- Revenue Next Year
- DDOG $18.94
- KVUE $3.52
- P/E Ratio
- DDOG $268.76
- KVUE $38.79
- Revenue Growth
- DDOG 25.54
- KVUE N/A
- 52 Week Low
- DDOG $81.63
- KVUE $17.67
- 52 Week High
- DDOG $170.08
- KVUE $25.17
- Technical
- Relative Strength Index (RSI)
- DDOG 66.52
- KVUE 37.24
- Support Level
- DDOG $119.56
- KVUE $21.12
- Resistance Level
- DDOG $123.69
- KVUE $22.14
- Average True Range (ATR)
- DDOG 3.52
- KVUE 0.56
- MACD
- DDOG 0.37
- KVUE -0.08
- Stochastic Oscillator
- DDOG 74.95
- KVUE 10.34
About DDOG Datadog Inc.
Datadog is a cloud-native company that focuses on analyzing machine data. The firm's product portfolio, delivered via software as a service, allows a client to monitor and analyze its entire IT infrastructure. Datadog's platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to utilize it for a variety of applications throughout their businesses.
About KVUE Kenvue Inc.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.